Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

CUSIP: 75383L102

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
+10,776,624
Put/Call ratio
72%
SEC-reported price per share
$29.70
Number of holders
123
Value change
+$335,895,056
Number of buys
86
Open additional details 1 more signal available
Number of sells
29
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
47,779,015

Security key

75383L102

Report period

Q3 2025

Institutions

123

Top holders

10

Ownership snapshot

Top reported holders of RAPP - Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Third Rock Ventures V, L.P.
Disclosed value leader
Third Rock Ventures V, L.P.
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 13F Lead comparable stake: 20% 13D/G row: Third Rock Ventures V, L.P. Showing 1-6 of 15 holder rows.

Quick read

Third Rock Ventures V, L.P. leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Third Rock Ventures V, L.P.'s linked filing trail.
Comparable ownership Top 5
Third Rock Ventures V, L.P. 20%
JOHNSON & JOHNSON 4.9%
Sofinnova Venture Partners XI, L.P. 4.2%
TRV GP V, LLC 15%
FMR LLC 11%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Third Rock Ventures V, L.P.
13D/G
20%
$81,198,952
7,135,233 shares
$0 31 Dec 2024
JOHNSON & JOHNSON
13D/G 13F
Company
4.9%
$53,000,690
1,784,517 shares
$0 30 Sep 2025
Sofinnova Venture Partners XI, L.P.
13D/G
Dr. James I. Healy ("Healy")
4.2%
$29,155,258
1,947,579 shares
$0 11 Sep 2025
TRV GP V, LLC
13F
Company
13F
15%
$81,127,599
7,135,233 shares
30 Jun 2025
FMR LLC
13F
Company
13F
11%
$62,246,578
5,474,633 shares
30 Jun 2025
ARCH Venture Management, LLC
13F
Company
13F
7.8%
$42,433,038
3,728,738 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
123
Shares
49,276,697
Rows available
123
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
81
Q3 2025 holders
123
Holder diff
42
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .